Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2024

Open Access 01-12-2024 | Post-COVID Syndrome | Study protocol

Efficacy of supervised immersive virtual reality-based training for the treatment of chronic fatigue in post-COVID syndrome: study protocol for a double-blind randomized controlled trial (IFATICO Trial)

Authors: Jonas Tesarz, Hannah Lange, Marietta Kirchner, Axel Görlach, Wolfgang Eich, Hans-Christoph Friederich

Published in: Trials | Issue 1/2024

Login to get access

Abstract

Background

The treatment of persistent fatigue after COVID-19 infection is complex. On the one hand, it involves maintaining a sufficient level of physical and mental activity to counteract possible degenerative processes of the body and nervous system. On the other hand, physical and mental activities can also lead to worsening of symptoms. Therefore, the challenge in treating Post-COVID fatigue is to stimulate the body and central nervous system in a way that stimulates growth and improvement, but does not overtax individual physical and mental limits. Special training programs try to take these characteristics into account, but often reach their limits. A promising approach is offered by new fitness technologies based on immersive virtual realities that stimulate both body and brain while minimizing physical and psychological stress. The aim of this study is to investigate the efficacy of supervised immersive Virtual Reality (VR)-based activity training compared to conventional activity training for patients with Post-COVID-associated fatigue.

Methods

In a single centre, individually randomised, prospective, double-blind two-arm exploratory superiority trial with parallel group design, N = 100 patients with persistent fatigue after COVID-19 infection will be recruited. The intervention includes a supervised immersive neuromuscular training (12 sessions of 30 min over 6 weeks) based on a novel VR-exercise device. We will systematically compare the effects of this intervention on Post-COVID-associated fatigue with a supervised conventional activation program of comparable scope without an immersive environment. The primary outcome is the difference between groups in absolute change in the mean fatigue symptom severity measured on the Fatigue Severity Scale (FSS) from baseline to posttreatment assessment. Posttreatment assessment in both groups will be conducted by blinded outcome assessors. At three and six months afterwards, patients are sent self-report questionnaires for follow up. The main analysis will be based on the intention-to-treat principle.

Discussion

To the best of our knowledge, this is the first exploratory study on a supervised immersive neuromuscular training for the treatment of persistent fatigue after COVID-19 infection.

Trial registration

German register for clinical studies (ID: DRKS00032059)
Prospectively registered on June 16th 2023.
URL of trial registration:
Appendix
Available only for authorised users
Literature
1.
2.
Koczulla AR, Ankermann T, Behrends U, Berlit P, Boing S, Brinkmann F, et al. S1 guideline post-COVID/Long-COVID. Pneumologie. 2021;75(11):869–900.PubMedCrossRef
3.
4.
Twomey R, DeMars J, Franklin K, Culos-Reed SN, Weatherald J, Wrightson JG. Chronic fatigue and Postexertional Malaise in people living with long COVID: an observational study. Phys Ther. 2022;102(4):pzac005.PubMedCrossRef
5.
Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13(1):5104.PubMedPubMedCentralCrossRef
6.
Peter RS, Nieters A, Krausslich HG, Brockmann SO, Gopel S, Kindle G, et al. Post-acute sequelae of covid-19 six to 12 months after infection: population based study. BMJ. 2022;379:e071050.PubMedCrossRef
7.
8.
9.
Humphreys H, Kilby L, Kudiersky N, Copeland R. Long COVID and the role of physical activity: a qualitative study. BMJ Open. 2021;11(3):e047632.PubMedCrossRef
10.
Shelley J, Hudson J, Mackintosh KA, Saynor ZL, Duckers J, Lewis KE, et al. “I live a kind of shadow life”: individual experiences of COVID-19 recovery and the impact on physical activity levels. Int J Environ Res Public Health. 2021;18(21):11417.PubMedPubMedCentralCrossRef
11.
Jimeno-Almazan A, Buendia-Romero A, Martinez-Cava A, Franco-Lopez F, Sanchez-Alcaraz BJ, Courel-Ibanez J, Pallares JG. Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations on recovery from post-COVID-19 conditions: the RECOVE trial (1985). J Appl Physiol. 2023;134(1):95–104.PubMedCrossRef
12.
de Sousa KCA, Gardel DG, Lopes AJ. Postural balance and its association with functionality and quality of life in non-hospitalized patients with post-acute COVID-19 syndrome. Physiother Res Int. 2022;27(4):e1967.PubMedPubMedCentralCrossRef
13.
Elhamrawy MY, Sherbini AehIes ME, Mokhtar MM, Mashaal A, Elkady SM, Elsadany SM, Said MT. Effect of Tai Chi versus aerobic training on improving hand grip strength, fatigue, and functional performance in older adults post-COVID-19: a randomized controlled trial. J Popul Ther Clin Pharmacol. 2023;30:190.
14.
Williams MD, Ramirez-Campillo R, Chaabene H, Moran J. Neuromuscular training and motor control in youth athletes: a meta-analysis. Percept Mot Skills. 2021;128(5):1975–97.PubMedPubMedCentralCrossRef
15.
Suchomel TJ, Nimphius S, Bellon CR, Stone MH. The importance of muscular strength: training considerations. Sports Med. 2018;48(4):765–85.PubMedCrossRef
16.
Debska M, Polechonski J, Mynarski A, Polechonski P. Enjoyment and intensity of physical activity in immersive virtual reality performed on innovative training devices in compliance with recommendations for health. Int J Environ Res Public Health. 2019;16(19):3673.PubMedPubMedCentralCrossRef
17.
18.
19.
20.
Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451–62.PubMedCrossRef
21.
Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.PubMedPubMedCentralCrossRef
22.
Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, Group CN. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for Nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–7.PubMedCrossRef
23.
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–3.PubMedCrossRef
24.
Goodwin E, Hawton A, Green C. Using the fatigue severity scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D). Health Qual Life Outcomes. 2019;17(1):136.PubMedPubMedCentralCrossRef
25.
Klok FA, Boon G, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The Post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1):2001494.PubMedPubMedCentralCrossRef
26.
Machado FVC, Meys R, Delbressine JM, Vaes AW, Goertz YMJ, van Herck M, et al. Construct validity of the Post-COVID-19 functional status scale in adult subjects with COVID-19. Health Qual Life Outcomes. 2021;19(1):40.PubMedPubMedCentralCrossRef
27.
28.
WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus. World Health Organization; 2021. Contract No.: WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.1.
29.
Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270(4):327–38.PubMedPubMedCentralCrossRef
30.
Scherr J, Wolfarth B, Christle JW, Pressler A, Wagenpfeil S, Halle M. Associations between Borg’s rating of perceived exertion and physiological measures of exercise intensity. Eur J Appl Physiol. 2013;113(1):147–55.PubMedCrossRef
31.
Hernandez-Belmonte A, Courel-Ibanez J, Conesa-Ros E, Martinez-Cava A, Pallares JG. Level of effort: a reliable and practical alternative to the velocity-based approach for monitoring resistance training. J Strength Cond Res. 2022;36(11):2992–9.PubMedCrossRef
32.
Jimeno-Almazan A, Pallares JG, Buendia-Romero A, Martinez-Cava A, Courel-Ibanez J. Chronotropic Incompetence in non-hospitalized patients with post-COVID-19 syndrome. J Clin Med. 2021;10(22):5434.PubMedPubMedCentralCrossRef
33.
Cattadori G, Di Marco S, Baravelli M, Picozzi A, Ambrosio G. Exercise training in post-COVID-19 patients: the need for a multifactorial protocol for a multifactorial pathophysiology. J Clin Med. 2022;11(8):2228.PubMedPubMedCentralCrossRef
34.
Chen H, Shi H, Liu X, Sun T, Wu J, Liu Z. Effect of pulmonary rehabilitation for patients with post-COVID-19: a systematic review and meta-analysis. Front Med (Lausanne). 2022;9:837420.PubMedCrossRef
35.
36.
Schubert T, Friedmann F, Regenbrecht H. The experience of presence: factor analytic insights. Pres Teleoper Virtual Environ. 2001;10:266.CrossRef
37.
Schubert T. The sense of presence in virtual environments: a three-component scale measuring spatial presence, involvement, and realness. J Media Psychol. 2003;15(2):69.
38.
Whitehead L. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage. 2009;37(1):107–28.PubMedCrossRef
39.
Reske D, Pukrop R, Scheinig K, Haupt WF, Petereit HF. Measuring fatigue in patients with multiple sclerosis with standardized methods in German speaking areas. Fortschr Neurol Psychiatr. 2006;74(9):497–502.PubMedCrossRef
40.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.PubMedCrossRef
41.
Cotler J, Holtzman C, Dudun C, Jason LA. A brief questionnaire to assess post-exertional malaise. Diagnostics (Basel). 2018;8(3):66.PubMedCrossRef
42.
Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988;41(4):313–21.PubMedCrossRef
43.
Sallis RE, Baggish AL, Franklin BA, Whitehead JR. The call for a physical activity vital sign in clinical practice. Am J Med. 2016;129(9):903–5.PubMedCrossRef
44.
Flor H, Rudy TE, Birbaumer N, Streit B, Schugens MM. [The applicability of the West Haven-Yale multidimensional pain inventory in German-speaking countries. Data on the reliability and validity of the MPI-D.]. Schmerz. 1990;4(2):82–7.PubMedCrossRef
45.
Marek EM, Friz Y, Pohl W, Vogel P, Muckenhoff K, Kotschy-Lang N, Marek W. Efficiency as a new parameter of physical fitness of patients in 6-minute-walk-test. Rehabilitation (Stuttg). 2011;50(2):118–26.PubMedCrossRef
46.
Jakel B, Kedor C, Grabowski P, Wittke K, Thiel S, Scherbakov N, et al. Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS. J Transl Med. 2021;19(1):159.PubMedPubMedCentralCrossRef
47.
Toussaint A, Murray AM, Voigt K, Herzog A, Gierk B, Kroenke K, et al. Development and validation of the Somatic Symptom Disorder-B criteria scale (SSD-12). Psychosom Med. 2016;78(1):5–12.PubMedCrossRef
48.
Toussaint A, Lowe B, Brahler E, Jordan P. The Somatic Symptom Disorder - B Criteria Scale (SSD-12): factorial structure, validity and population-based norms. J Psychosom Res. 2017;97:9–17.PubMedCrossRef
49.
Gierk B, Kohlmann S, Kroenke K, Spangenberg L, Zenger M, Brahler E, Lowe B. The somatic symptom scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Intern Med. 2014;174(3):399–407.PubMedCrossRef
50.
Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.PubMedCrossRef
51.
Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ. 2005;6(2):124–30.PubMedCrossRef
52.
Nordin A, Taft C, Lundgren-Nilsson A, Dencker A. Minimal important differences for fatigue patient reported outcome measures-a systematic review. BMC Med Res Methodol. 2016;16:62.PubMedPubMedCentralCrossRef
53.
Robinson D Jr, Zhao N, Gathany T, Kim LL, Cella D, Revicki D. Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial. Curr Med Res Opin. 2009;25(5):1121–30.PubMedCrossRef
54.
Goligher EC, Pouchot J, Brant R, Kherani RB, Avina-Zubieta JA, Lacaille D, et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol. 2008;35(4):635–42.PubMed
55.
Jimeno-Almazan A, Franco-Lopez F, Buendia-Romero A, Martinez-Cava A, Sanchez-Agar JA, Sanchez-Alcaraz Martinez BJ, et al. Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: a randomized controlled trial. Scand J Med Sci Sports. 2022;32(12):1791–801.PubMedCrossRef
56.
Rooney S, McFadyen DA, Wood DL, Moffat DF, Paul PL. Minimally important difference of the fatigue severity scale and modified fatigue impact scale in people with multiple sclerosis. Mult Scler Relat Disord. 2019;35:158–63.PubMedCrossRef
57.
Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, Group C. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med. 2008;148(4):W60-6.PubMedCrossRef
58.
Monaghan TF, Agudelo CW, Rahman SN, Wein AJ, Lazar JM, Everaert K, Dmochowski RR. Blinding in clinical trials: seeing the big picture. Medicina (Kaunas). 2021;57(7):647.PubMedCrossRef
59.
van der Kolk NM, de Vries NM, Kessels RPC, Joosten H, Zwinderman AH, Post B, Bloem BR. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson’s disease: a double-blind, randomised controlled trial. Lancet Neurol. 2019;18(11):998–1008.PubMedCrossRef
60.
Froehlich L, Hattesohl DBR, Jason LA, Scheibenbogen C, Behrends U, Thoma M. Medical care situation of people with myalgic encephalomyelitis/chronic fatigue syndrome in Germany. Medicina (Kaunas). 2021;57(7):646.PubMedCrossRef
61.
Jason LA, So S, Evans M, Brown A, Sunnquist M, Im Y, Schafer C. An overview of operationalizing criteria for ME, ME/CFS, and CFS case definitions. J Prev Interv Community. 2015;43(1):1–4.PubMedCrossRef
62.
NINDS. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Post Exertional Malaise Subgroup. 2017.
63.
64.
Gierk B, Kohlmann S, Hagemann-Goebel M, Lowe B, Nestoriuc Y. Monitoring somatic symptoms in patients with mental disorders: Sensitivity to change and minimal clinically important difference of the Somatic Symptom Scale - 8 (SSS-8). Gen Hosp Psychiatry. 2017;48:51–5.PubMedCrossRef
65.
Toussaint A, Husing P, Kohlmann S, Lowe B. Detecting DSM-5 somatic symptom disorder: criterion validity of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder - B criteria scale (SSD-12). Psychol Med. 2020;50(2):324–33.PubMedCrossRef
66.
Bayraktar D, Yuksel Karsli T, Ozer Kaya D, Sarac DC, Gucenmez S, Gercik O, et al. Is the international physical activity questionnaire (IPAQ) a valid assessment tool for measuring physical activity of patients with axial spondyloartritis? Musculoskelet Sci Pract. 2021;55:102418.PubMedCrossRef
67.
Fabbri M, Beracci A, Martoni M, Meneo D, Tonetti L, Natale V. Measuring subjective sleep quality: a review. Int J Environ Res Public Health. 2021;18(3):1082.PubMedPubMedCentralCrossRef
68.
Juhola J, Arokoski JPA, Ervasti J, Kivimaki M, Vahtera J, Myllyntausta S, Saltychev M. Internal consistency and factor structure of Jenkins sleep scale: cross-sectional cohort study among 80 000 adults. BMJ Open. 2021;11(1):e043276.PubMedPubMedCentralCrossRef
69.
Tibubos AN, Zenger M, Schmalbach B, Beutel ME, Brahler E. Measurement invariance, validation and normative data of the Jenkins Sleep Scale-4 (JSS-4) in the German general population across the life span. J Psychosom Res. 2020;130:109933.PubMedCrossRef
70.
Phelps C, Bellon S, Hinkey M, Nash A, Boyd J, Cook CE, Garcia AN. Measurement properties of patient-reported outcome measures used to assess the sleep quality in adults with high prevalence chronic pain conditions: a systematic review. Sleep Med. 2020;74:315–31.PubMedCrossRef
71.
Laranjo L, Ding D, Heleno B, Kocaballi B, Quiroz JC, Tong HL, et al. Do smartphone applications and activity trackers increase physical activity in adults? Systematic review, meta-analysis and metaregression. Br J Sports Med. 2021;55(8):422–32.PubMedCrossRef
72.
Reitan RM. Trail making test: manual for administration and scoring. Tucson: Reitan Neuropsychology Laboratory; 1992.
73.
Tischler L, Petermann F. Testbesprechung Trail Making Test (TMT), Zeitschrift für Psychiatrie Psychologie und Psychotherapie. 2010.
74.
Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643–62.CrossRef
75.
76.
Kirchner WK. Age differences in short-term retention of rapidly changing information. J Exp Psychol. 1958;55(4):352–8.PubMedCrossRef
77.
Jaeggi SM, Buschkuehl M, Perrig WJ, Meier B. The concurrent validity of the N-back task as a working memory measure. Memory. 2010;18(4):394–412.PubMedCrossRef
78.
79.
Ruchinskas R. Wechsler adult intelligence scale-4th edition digit span performance in subjective cognitive complaints, amnestic mild cognitive impairment, and probable dementia of the Alzheimer type. Clin Neuropsychol. 2019;33(8):1436–44.PubMedCrossRef
80.
Alberts J, Lowe B, Glahn MA, Petrie K, Laferton J, Nestoriuc Y, Shedden-Mora M. Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews. BMJ Open. 2020;10(8):e036169.PubMedPubMedCentralCrossRef
81.
van Buuren S, Brand JPL, Groothuis-Oudshoorn CGM, Rubin DB. Fully conditional specification in multivariate imputation. J Stat Comput Simul. 2006;76(12):1049–64.CrossRef
82.
Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863.PubMedPubMedCentralCrossRef
83.
Team RC. R: A language and environment for statistical computing. MSOR connections. 2014;1.
84.
Grant S, Mayo-Wilson E, Montgomery P, Macdonald G, Michie S, Hopewell S, et al. CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials. Trials. 2018;19(1):406.PubMedPubMedCentralCrossRef
85.
Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, et al. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials. BMJ. 2023;381:e073725.PubMedCrossRef
Metadata
Title
Efficacy of supervised immersive virtual reality-based training for the treatment of chronic fatigue in post-COVID syndrome: study protocol for a double-blind randomized controlled trial (IFATICO Trial)
Authors
Jonas Tesarz
Hannah Lange
Marietta Kirchner
Axel Görlach
Wolfgang Eich
Hans-Christoph Friederich
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Trials / Issue 1/2024
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-024-08032-w

Other articles of this Issue 1/2024

Trials 1/2024 Go to the issue

Study protocol

Study protocol for a randomised cross-over trial of Neurally adjusted ventilatory Assist for Neonates with Congenital diaphragmatic hernias: the NAN-C study

Study protocol

Sacral neuromodulation for constipation and fecal incontinence in children and adolescents – study protocol of a prospective, randomized trial on the application of invasive vs. non-invasive technique

Study protocol

PeRsOnaliSed care Planning for oldER people with frailty (PROSPER): protocol for a randomised controlled trial

Study protocol

Effectiveness of personalized meal recommendation in improving dietary behaviors of Chinese community-dwelling elders: study protocol for a cluster randomized controlled trial

Study protocol

Community Health workers United to Reduce Colorectal cancer and cardiovascular disease among people at Higher risk (CHURCH): study protocol for a randomized controlled trial

Correction

Correction: Clinical and cost-effectiveness of a New psychosocial intervention to support Independence in Dementia (NIDUS-family) for family carers and people living with dementia in their own homes: a randomised controlled trial